Author(s): Liu X, Lv C, Luan X, Lv M
Abstract Share this page
Abstract The C282Y and H63D polymorphisms in the HFE gene have been implicated in susceptibility of breast cancer, but a number of studies have reported inconclusive results. The aim of this study is to investigate the association between the C282Y and H63D polymorphisms in the HFE gene and breast cancer risk by meta-analysis. We searched PubMed and Embase databases, covering all related studies until March 2, 2013. Statistical analysis was performed using STATA 10.0. A total of 7 studies including 1,720 cases and 18,296 controls for HFE C282Y polymorphism and 5 studies including 942 cases and 1,571 controls for HFE H63D polymorphism were included in the meta-analysis. The results showed that HFE C282Y polymorphism was significantly associated with increased risk of breast cancer under homozygotes vs. wild-type model (OR = 2.06, 95\%CI = 1.19-3.58) and recessive model (OR = 1.98, 95\%CI = 1.14-3.44) but not under heterozygotes vs. wild-type model (OR = 0.97, 95\%CI = 0.70-1.35), dominant model (OR = 1.00, 95\%CI = 0.72-1.40) and multiplicative model (OR = 1.04, 95\%CI = 0.76-1.42). However, we did not find any association between HFE H63D polymorphism and breast cancer risk under all genetic models. This current meta-analysis suggested that C282Y polymorphism rather than H63D might be associated with increased risk of breast cancer.
This article was published in Tumour Biol
and referenced in Journal of Cancer Science & Therapy